Neogenomics Inc’s filing revealed that its Officer WARREN STONE acquired Company’s shares for reported $0.28 million on Jan 20 ’26. In the deal valued at $12.79 per share,22,128 shares were bought.
Then, Olivo Alicia C sold 20,916 shares, generating $250,992 in total proceeds. Upon selling the shares at $12.00, the EVP, GC & Business Development now owns 31,083 shares.
Before that, ALICIA OLIVO bought 11,939 shares. Neogenomics Inc shares valued at $138,612 were divested by the Officer at a price of $11.61 per share.
BTIG Research downgraded its Neogenomics Inc [NEO] rating to a Neutral from a a Buy in a research note published recently. A number of analysts have revised their coverage, including William Blair’s analysts, who decreased its forecast for the stock in late July from “an Outperform” to “a Mkt perform”. Guggenheim began covering NEO with “Neutral” recommendation on May 15, 2025. Leerink Partners revised its rating on April 30, 2025. It rated NEO as “a Market perform” which previously was an “an Outperform”.
Price Performance Review of NEO
On Tuesday, Neogenomics Inc [NASDAQ:NEO] saw its stock fall -1.17% to $12.64. Over the last five days, the stock has gained 1.20%. Neogenomics Inc shares have fallen nearly -9.59% since the year began. Nevertheless, the stocks have risen 7.48% over the past one year.
How much short interest is there in Neogenomics Inc?
A steep rise in short interest was recorded in Neogenomics Inc stocks on 2025-12-31, dropping by -1.19 million shares to a total of 7.87 million shares. Yahoo Finance data shows the prior-month short interest on 2025-11-28 was 9.05 million shares. There was a decline of -15.08%, which implies that there is a negative sentiment for the stock.
